SFG
ONC

Steward Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Steward Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$6K Buy
+35
New +$6.92K ﹤0.01% 580

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Steward Financial Group's ONC Position: Q3 2023 in Review

Steward Financial Group opened a new position in BeOne Medicines Ltd (ONC) in Q3 2023: 35 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings.

200 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

  • Steward Financial Group held 35 shares of BeOne Medicines Ltd worth $6K as of Q3 2023.
  • BeOne Medicines Ltd was a new Steward Financial Group position in Q3 2023.
  • BeOne Medicines Ltd made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #580 holding.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.